Asthma Management - 2.26.2021

What’s New? GINA 2020 Updates

Presented by:

Joy Leotsakos, PharmD

 

Live Location:

Virtual webinar Link provided via email

 

CME Course Director: Jonathan Harland, MD

CNE Course Advisor: Carmela Townsend, DNP, MS/MBA, RN

 Target audience: All Atrius Primary Care Clinicians

 

AGENDA

12:00PM- 12:55 PM  Welcome and Presentation

12:55 PM-1:00 PM Discussion/Q&A

 

 

Accreditation Statements

CME Accreditation

Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

 

Boston University School of Medicine designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Risk Management

This program meets the criteria of the Massachusetts Board of Registration in Medicine for risk management study.

 

NCPD Accreditation

Boston University School of Medicine Continuing Nursing Education Provider Unit is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

 

Contact Hours: 1.00, all of which are eligible for pharmacology credit.

 

Educational Objectives

At the conclusion of this activity, participants will be able to:

1. Identify GINA 2020 recommendation changes and how they should be interpreted during the COVID pandemic

2. Analyze the data supporting the new treatment strategies presented in GINA 2020 recommendations

3. Apply asthma treatment and management during the COVID pandemic to special populations

4. Discuss the place in therapy of new drugs for treating asthma

5. Locate tools available for asthma management at Atrius

 

References

See presentation slides.

 

Disclosure Statements

 

CME Course Director

Jonathan Harland, MD does not have anything to disclose with regard to commercial interests.

 

CNE Course Advisor

Carmela Townsend, DNP, MS/MBA, RN does not have anything to disclose with regard to commercial interests.

 

Faculty

Joy Leotsakos, PharmD, Presenter has no relevant financial relationships to disclose.

Faculty does not plan on discussing unlabeled/investigational uses of a commercial product.

 

Boston University Planners

The lead nursing planner, Carmela A. Townsend, DNP, MS/MBA, RN, and the BU program manager, Sakina Flint, do not have anything to disclose with regard to commercial interests.

 

For successful completion of this activity, learners must attend live activity and complete the evaluation:

  • Attend live activity
  • Complete the evaluation

Go to https://cme.bu.edu/code, enter activity code (see below) to claim credits/get certificate.

 

Disclaimer

ALL PROGRAMS, ACTIVITIES, AND MATERIALS PROVIDED BY BOSTON UNIVERSITY OFFICE OF CONTINUING MEDICAL EDUCATION OR ITS ASSOCIATES ARE PROVIDED ON THE CONDITION THAT THEY BE USED SOLELY FOR EDUCATIONAL PURPOSES BY QUALIFIED HEALTH CARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE CONTINUING MEDICAL EDUCATION PROGRAMS, ACTIVITIES OR MATERIALS. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE.  NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED.

 

Atrius Health

Target Audience

(See above)

Learning Objectives

(See above)

Course summary
Available credit: 
  • 0.00 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Enduring activity for a maximum of 0.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 0.00 ANCC
  • 1.00 Participation
Course opens: 
02/26/2021
Course expires: 
02/26/2022
Rating: 
0
COP
MA
United States

Joy Leotsakos, PharmD, Presenter has no relevant financial relationships to disclose.

Faculty does not plan on discussing unlabeled/investigational uses of a commercial product.

(See above)

Available Credit

  • 0.00 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Enduring activity for a maximum of 0.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 0.00 ANCC
  • 1.00 Participation
Please login or register to take this course.